Recordati Sets 3-Year Goals Driven By Organic Growth & M&A
By Karen Roman Recordati said it established its three-year financial targets for 2025-2027, with expected...
Editorial
Araris Biotech Partners with Johnson & Johnson to Develop Cancer Therapies
By Daniella Parra Araris Biotech AG joined a research agreement with Johnson & Johnson’s Janssen...
ReAlta Life Sciences Presents Data for Hypoxic Ischemic Encephalopathy at PAS Meeting 2025
By Karen Roman ReAlta Life Sciences said it is presenting new data from its hypoxic...
Patient Impact: BioStem Technologies CEO Jason Matuszewski, Live from Nasdaq
Tech Edge hosted a fireside chat on April 22 at Nasdaq MarketSite with Jason Matuszewski,...
March Bio Starts Phase 2 Trial for Rare Blood Cancer
By Karen Roman March Biosciences said it started Phase 2 trial for MB-105, its CAR-T...
Ascentage Pharma Drugs Included in Chinese Society of Clinical Oncology Guidelines
By Karen Roman Ascentage Pharma Group Internat (Nasdaq: AAPG) said two of its proprietary drugs...
Nanox New Imaging System Receives FDA Clearance
By Karen Roman Nano-X Imaging Ltd. (Nasdaq: NNOX) said its multi-source digital imaging system, Nanox.ARC...
Tech Edge Live at RSA Conference for Interviews April 28 – May 1
Tech Edge will be attending the RSA Conference 2025 at the Moscone Center in San...
Exec Edge Launches Research Coverage with Initiation Notes on FLD, CLYM, STKS, REX
By Exec Edge Editorial Staff Exec Edge today announced the formal launch of Exec Edge...
The ONE Group Hospitality: Serving More Steaks and Shareholders with Benihana Deal – Initiation Report
Visit Exec Edge Research for Full Report By Rayk Riechmann How about steak and a...
© Copyright 2025, ExecEdge